Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 660

1.

Molecular Organization and Assembly of the Export Apparatus of Flagellar Type III Secretion Systems.

Minamino T, Kawamoto A, Kinoshita M, Namba K.

Curr Top Microbiol Immunol. 2019 Jun 7. doi: 10.1007/82_2019_170. [Epub ahead of print]

PMID:
31172377
2.

Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells.

Yoshioka T, Shien K, Takeda T, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Soh J, Fujiwara T, Toyooka S.

Cancer Sci. 2019 Jun 4. doi: 10.1111/cas.14089. [Epub ahead of print]

3.

Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies.

Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S.

Graefes Arch Clin Exp Ophthalmol. 2019 May 7. doi: 10.1007/s00417-019-04330-1. [Epub ahead of print]

PMID:
31065846
4.

Structural Insights into the Substrate Specificity Switch Mechanism of the Type III Protein Export Apparatus.

Inoue Y, Ogawa Y, Kinoshita M, Terahara N, Shimada M, Kodera N, Ando T, Namba K, Kitao A, Imada K, Minamino T.

Structure. 2019 Jun 4;27(6):965-976.e6. doi: 10.1016/j.str.2019.03.017. Epub 2019 Apr 25.

PMID:
31031200
5.

A case of nodular posterior scleritis simulating intraocular tumor.

Shibata Y, Kase S, Namba K, Ishida S.

Int J Ophthalmol. 2019 Apr 18;12(4):685-688. doi: 10.18240/ijo.2019.04.26. eCollection 2019. No abstract available.

6.

Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis.

Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S.

Am J Ophthalmol Case Rep. 2019 Mar 23;14:87-91. doi: 10.1016/j.ajoc.2019.03.005. eCollection 2019 Jun.

7.

A Concise Asymmetric Total Synthesis of (+)-Epilupinine.

Tsutsumi T, Karanjit S, Nakayama A, Namba K.

Org Lett. 2019 Apr 19;21(8):2620-2624. doi: 10.1021/acs.orglett.9b00607. Epub 2019 Apr 9.

PMID:
30963767
8.

Mutational analysis of the C-terminal cytoplasmic domain of FlhB, a transmembrane component of the flagellar type III protein export apparatus in Salmonella.

Inoue Y, Kinoshita M, Namba K, Minamino T.

Genes Cells. 2019 Apr 8. doi: 10.1111/gtc.12684. [Epub ahead of print]

PMID:
30963674
9.

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.

Kurihara E, Shien K, Torigoe H, Takeda T, Takahashi Y, Ogoshi Y, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Okazaki M, Shien T, Tomida S, Toyooka S.

Anticancer Res. 2019 Apr;39(4):1767-1775. doi: 10.21873/anticanres.13283.

PMID:
30952716
10.

Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.

Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S.

Curr Eye Res. 2019 Apr 5:1-10. doi: 10.1080/02713683.2019.1600197. [Epub ahead of print]

PMID:
30947551
11.

Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.

Sato H, Soh J, Aoe K, Fujimoto N, Tanaka S, Namba K, Torigoe H, Shien K, Yamamoto H, Tomida S, Tao H, Okabe K, Kishimoto T, Toyooka S.

Int J Oncol. 2019 Jun;54(6):2139-2148. doi: 10.3892/ijo.2019.4768. Epub 2019 Apr 1.

PMID:
30942424
12.

Novel Insights into Conformational Rearrangements of the Bacterial Flagellar Switch Complex.

Sakai T, Miyata T, Terahara N, Mori K, Inoue Y, Morimoto YV, Kato T, Namba K, Minamino T.

MBio. 2019 Apr 2;10(2). pii: e00079-19. doi: 10.1128/mBio.00079-19.

13.

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations.

Ogoshi Y, Shien K, Yoshioka T, Torigoe H, Sato H, Sakaguchi M, Tomida S, Namba K, Kurihara E, Takahashi Y, Suzawa K, Yamamoto H, Soh J, Toyooka S.

Oncol Lett. 2019 Mar;17(3):2729-2736. doi: 10.3892/ol.2019.9908. Epub 2019 Jan 8.

14.

Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.

Takeuchi M, Kanda T, Kaburaki T, Tanaka R, Namba K, Kamoi K, Maruyama K, Shibuya E, Mizuki N.

Medicine (Baltimore). 2019 Mar;98(9):e14668. doi: 10.1097/MD.0000000000014668.

15.

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.

Namba K, Tomida S, Matsubara T, Takahashi Y, Kurihara E, Ogoshi Y, Yoshioka T, Takeda T, Torigoe H, Sato H, Shien K, Yamamoto H, Soh J, Tsukuda K, Toyooka S.

BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1.

16.

Precision microcatheter shaping in vertebrobasilar aneurysm coiling.

Namba K, Higaki A, Kaneko N, Nemoto S, Kawai K.

Interv Neuroradiol. 2019 Feb 25:1591019918824012. doi: 10.1177/1591019918824012. [Epub ahead of print]

PMID:
30803335
17.

Complementary Use of Electron Cryomicroscopy and X-Ray Crystallography: Structural Studies of Actin and Actomyosin Filaments.

Fujii T, Namba K.

Adv Exp Med Biol. 2018;1105:25-42. doi: 10.1007/978-981-13-2200-6_4.

PMID:
30617822
18.

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Namba K, Shien K, Takahashi Y, Torigoe H, Sato H, Yoshioka T, Takeda T, Kurihara E, Ogoshi Y, Yamamoto H, Soh J, Tomida S, Toyooka S.

Mol Cancer Res. 2019 Feb;17(2):499-507. doi: 10.1158/1541-7786.MCR-18-0628. Epub 2018 Nov 21.

PMID:
30463991
19.

Characteristics of self-reported daily life note (LN) users in return-to-work judgment for workers on sick leave due to mental health conditions, and usefulness of the tool.

Kusumoto A, Kajiki S, Fujino Y, Namba K, Nagata T, Nagata M, Tsutsumi A, Mori K.

Ind Health. 2019 Feb 5;57(1):70-78. doi: 10.2486/indhealth.2018-0028. Epub 2018 Nov 17.

20.

Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.

Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M.

Int J Cancer. 2019 Jul 15;145(2):569-575. doi: 10.1002/ijc.31982. Epub 2018 Dec 14.

PMID:
30414170
21.

Association Study of ARMC9 Gene Variants with Vogt-Koyanagi-Harada Disease in Japanese Patients.

Ohno T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N.

Ocul Immunol Inflamm. 2018 Nov 5:1-7. doi: 10.1080/09273948.2018.1523438. [Epub ahead of print]

PMID:
30395750
22.

exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.

Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M.

Int J Cancer. 2019 Jun 15;144(12):3138-3145. doi: 10.1002/ijc.31945. Epub 2018 Dec 4.

PMID:
30365872
23.

Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.

Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S.

Ocul Immunol Inflamm. 2018 Oct 18:1-9. doi: 10.1080/09273948.2018.1533984. [Epub ahead of print]

PMID:
30335535
24.

Synthesis and Evaluation of a 1,3a,6a-Triazapentalene (TAP)-Bonded System.

Ito M, Mera A, Mashimo T, Seki T, Karanjit S, Ohashi E, Nakayama A, Kitamura K, Hamura T, Ito H, Namba K.

Chemistry. 2018 Dec 3;24(67):17727-17733. doi: 10.1002/chem.201804733. Epub 2018 Nov 26.

PMID:
30298702
25.

Organic Chemistry Research on the Mechanistic Elucidation of Iron Acquisition in Barley.

Namba K, Murata Y.

Biol Pharm Bull. 2018;41(10):1502-1507. doi: 10.1248/bpb.b18-00070. Review.

26.

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.

Takahashi Y, Shien K, Tomida S, Oda S, Matsubara T, Sato H, Suzawa K, Kurihara E, Ogoshi Y, Namba K, Yoshioka T, Torigoe H, Yamamoto H, Soh J, Toyooka S.

Cancer Sci. 2018 Nov;109(11):3634-3642. doi: 10.1111/cas.13797. Epub 2018 Oct 6.

27.

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.

Sato H, Yamamoto H, Sakaguchi M, Shien K, Tomida S, Shien T, Ikeda H, Hatono M, Torigoe H, Namba K, Yoshioka T, Kurihara E, Ogoshi Y, Takahashi Y, Soh J, Toyooka S.

Cancer Sci. 2018 Oct;109(10):3183-3196. doi: 10.1111/cas.13763. Epub 2018 Sep 14.

28.

Autonomous control mechanism of stator assembly in the bacterial flagellar motor in response to changes in the environment.

Minamino T, Terahara N, Kojima S, Namba K.

Mol Microbiol. 2018 Sep;109(6):723-734. doi: 10.1111/mmi.14092. Epub 2018 Sep 16. Review.

PMID:
30069936
29.

Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.

Habu T, Soh J, Toji T, Shien K, Niman E, Namba K, Sato H, Yamamoto H, Sugimoto S, Yamane M, Toyooka S.

Jpn J Clin Oncol. 2018 Sep 1;48(9):851-854. doi: 10.1093/jjco/hyy100.

PMID:
30053180
30.

Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials.

Goto H, Zako M, Namba K, Hashida N, Kaburaki T, Miyazaki M, Sonoda KH, Abe T, Mizuki N, Kamoi K, Brézin AP, Dick AD, Jaffe GJ, Nguyen QD, Inomata N, Kwatra NV, Camez A, Song AP, Kron M, Tari S, Ohno S.

Ocul Immunol Inflamm. 2019;27(1):40-50. doi: 10.1080/09273948.2018.1491605. Epub 2018 Jul 17.

PMID:
30015528
31.

Acceleration of hydrogen absorption by palladium through surface alloying with gold.

Namba K, Ogura S, Ohno S, Di W, Kato K, Wilde M, Pletikosić I, Pervan P, Milun M, Fukutani K.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):7896-7900. doi: 10.1073/pnas.1800412115. Epub 2018 Jul 13.

32.

In Vitro Reconstitution of Functional Type III Protein Export and Insights into Flagellar Assembly.

Terashima H, Kawamoto A, Tatsumi C, Namba K, Minamino T, Imada K.

MBio. 2018 Jun 26;9(3). pii: e00988-18. doi: 10.1128/mBio.00988-18.

33.

Quantitation of sevoflurane in whole blood and aqueous solutions by volatile organic compound sensing.

Hase Y, Suzuki K, Kamekura N, Shibuya M, Takahashi Y, Namba K, Fujisawa T.

J Pharmacol Toxicol Methods. 2018 Nov - Dec;94(Pt 1):71-76. doi: 10.1016/j.vascn.2018.05.005. Epub 2018 Jun 1.

PMID:
29859814
34.

Two cases of cytomegalovirus panuveitis in immunocompetent patients.

Sakai M, Takase H, Namba K, Mizuuchi K, Iwata D, Ishida S.

Am J Ophthalmol Case Rep. 2018 Jan 17;10:189-191. doi: 10.1016/j.ajoc.2018.01.025. eCollection 2018 Jun.

35.

Insight into structural remodeling of the FlhA ring responsible for bacterial flagellar type III protein export.

Terahara N, Inoue Y, Kodera N, Morimoto YV, Uchihashi T, Imada K, Ando T, Namba K, Minamino T.

Sci Adv. 2018 Apr 25;4(4):eaao7054. doi: 10.1126/sciadv.aao7054. eCollection 2018 Apr.

36.

Direct Synthesis of Polycyclic Tropinones by a Condensation-[4+3]-Cycloaddition Cascade Reaction.

Okamoto T, Shibata M, Karanjit S, Nakayama A, Yoshida M, Namba K.

Chemistry. 2018 Jul 5;24(38):9508-9513. doi: 10.1002/chem.201802011. Epub 2018 Jun 10.

PMID:
29701268
37.

Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds.

Kitao K, Mutai H, Namba K, Morimoto N, Nakano A, Arimoto Y, Sugiuchi T, Masuda S, Okamoto Y, Morita N, Sakamoto H, Shintani T, Fukuda S, Kaga K, Matsunaga T.

Ear Hear. 2019 Jan/Feb;40(1):184-191. doi: 10.1097/AUD.0000000000000586.

PMID:
29688962
38.

Evidence for the hook supercoiling mechanism of the bacterial flagellum.

Fujii T, Matsunami H, Inoue Y, Namba K.

Biophys Physicobiol. 2018 Feb 6;15:28-32. doi: 10.2142/biophysico.15.0_28. eCollection 2018.

39.

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.

Torigoe H, Yamamoto H, Sakaguchi M, Youyi C, Namba K, Sato H, Shien K, Soh J, Suzawa K, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.

Carcinogenesis. 2018 May 3;39(5):719-727. doi: 10.1093/carcin/bgy044.

PMID:
29546323
40.

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

Torigoe H, Shien K, Takeda T, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Sakaguchi M, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.

Cancer Sci. 2018 May;109(5):1493-1502. doi: 10.1111/cas.13571. Epub 2018 Apr 15.

41.

Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.

Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.

Cancer Sci. 2018 Apr;109(4):1166-1176. doi: 10.1111/cas.13546. Epub 2018 Mar 25.

42.

Effect of a clockwise-locked deletion in FliG on the FliG ring structure of the bacterial flagellar motor.

Kinoshita M, Namba K, Minamino T.

Genes Cells. 2018 Mar;23(3):241-247. doi: 10.1111/gtc.12565. Epub 2018 Feb 6.

43.

Novel insights into the mechanism of well-ordered assembly of bacterial flagellar proteins in Salmonella.

Inoue Y, Morimoto YV, Namba K, Minamino T.

Sci Rep. 2018 Jan 29;8(1):1787. doi: 10.1038/s41598-018-20209-3.

44.

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.

Sato H, Sakaguchi M, Yamamoto H, Tomida S, Aoe K, Shien K, Yoshioka T, Namba K, Torigoe H, Soh J, Tsukuda K, Tao H, Okabe K, Miyoshi S, Pass HI, Toyooka S.

Oncogenesis. 2018 Jan 24;7(1):11. doi: 10.1038/s41389-017-0017-3.

45.

Electrical Matching at Metal/Molecule Contacts for Efficient Heterogeneous Charge Transfer.

Sato S, Iwase S, Namba K, Ono T, Hara K, Fukuoka A, Uosaki K, Ikeda K.

ACS Nano. 2018 Feb 27;12(2):1228-1235. doi: 10.1021/acsnano.7b07223. Epub 2018 Jan 18.

PMID:
29323878
46.

Insight into adaptive remodeling of the rotor ring complex of the bacterial flagellar motor.

Kinoshita M, Furukawa Y, Uchiyama S, Imada K, Namba K, Minamino T.

Biochem Biophys Res Commun. 2018 Jan 29;496(1):12-17. doi: 10.1016/j.bbrc.2017.12.118. Epub 2017 Dec 30.

PMID:
29294326
47.

A triangular loop of domain D1 of FlgE is essential for hook assembly but not for the mechanical function.

Sakai T, Inoue Y, Terahara N, Namba K, Minamino T.

Biochem Biophys Res Commun. 2018 Jan 8;495(2):1789-1794. doi: 10.1016/j.bbrc.2017.12.037. Epub 2017 Dec 8.

PMID:
29229393
48.

Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

Torigoe H, Soh J, Tomida S, Namba K, Sato H, Katsui K, Hotta K, Shien K, Yamamoto H, Yamane M, Kanazawa S, Kiura K, Miyoshi S, Toyooka S.

J Thorac Dis. 2017 Sep;9(9):3076-3086. doi: 10.21037/jtd.2017.08.87.

49.

Na+-induced structural transition of MotPS for stator assembly of the Bacillus flagellar motor.

Terahara N, Kodera N, Uchihashi T, Ando T, Namba K, Minamino T.

Sci Adv. 2017 Nov 1;3(11):eaao4119. doi: 10.1126/sciadv.aao4119. eCollection 2017 Nov.

50.

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Chen H, Shien K, Suzawa K, Tsukuda K, Tomida S, Sato H, Torigoe H, Watanabe M, Namba K, Yamamoto H, Soh J, Asano H, Miyoshi S, Toyooka S.

Oncol Lett. 2017 Oct;14(4):4349-4354. doi: 10.3892/ol.2017.6678. Epub 2017 Jul 26.

Supplemental Content

Support Center